England's NHS is testing an artificial pancreas for children with Type 1 diabetes, a device already available in India.

Roche is teaming up with two medical tech companies to develop an automated insulin delivery system, the first steps towards an ‘artificial pancreas.’ The Swiss pharma will work with existing ...

However, now only the Medtronic Revo system has obtained FDA ... The change of reed-switch to a Hall sensor. Furthermore, it has developed simple programming with clear steps to provide ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

Continuous Glucose Monitoring (CGM) is transforming diabetes care in India, where the disease has reached alarming rates. Continuous Glucose Monitoring is truly a game-changer for diabetes management.

Meanwhile, Abbott's FreeStyle Libre and FreeStyle Libre 2 flash CGM systems remain available to patients and listed on the NHS Drug Tariff. The FreeStyle Libre 3 system consists of the sensor ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the agency’s contentious LDT final rule is challenged in court. Donald Trump’s first ...